AIM ImmunoTech Inc. — Director's Dealing 2013

Jun 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2013-06-06

Reporting Person: Equels Thomas K. (Director, Exec Vice Chairman,Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-06	Options to buy Common Stock	$0.31	J	300000	Acquired	2023-06-06	Common Stock (300000)	Direct

Footnotes

F1: Stock options issued per his employee agreement.